Evidence map›Paper›PMID 41340803›Full record

ReviewActa clinica Croatica2025

VITAMIN D IN PATIENTS WITH INFLAMMATORY SKIN DISEASES.

Liborija Lugović-Mihić, Maja Tolušić Levak, Sara Špičić, Vedrana Bulat, Ana Brkić, Ana Šešerko

Abstract readReview
In one paragraph

Review in Acta clinica Croatica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Liborija Lugović-MihićDepartment of Dermatovenereology, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Maja Tolušić LevakDepartment of Dermatovenereology, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Sara ŠpičićDepartment of Dermatovenereology, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Vedrana BulatDepartment of Dermatovenereology, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Ana BrkićDepartment of Dermatovenereology, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Ana ŠešerkoDepartment of Gynecology and Obstetrics, Zagreb University Hospital Center, Zagreb, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In search for the ways to cure and improve skin condition of patients with inflammatory skin diseases, vitamin D supplementation has been shown to be useful, primarily due to its effects on a number of skin functions, e.g., keratinocyte proliferation, differentiation and apoptosis, maintenance of the epidermal barrier, and regulation of immune processes in the skin, among others. Vitamin D is essential for good general health and healthy skin, but deficiency can occur due to various factors that result in increased time spent indoors and limited sunlight exposure, such as geography (place of residence) and genetic factors. Although some results are inconsistent, previous research indicates that multiple inflammatory skin diseases can be affected by vitamin D deficiency, particularly atopic dermatitis, but also other inflammatory skin diseases. There is also evidence for an association between vitamin D deficiency and the risk of worsening of skin diseases such as psoriasis, chronic urticaria, contact dermatitis, etc. For these and several other inflammatory skin diseases, most research suggests that patients benefit from vitamin D supplementation.

Indexed as

Chronic UrticariaDermatitis, AtopicDermatitis, ContactPsoriasisVitamin DVitamin D DeficiencyDietary SupplementsHumansSkinSunlightVitaminsVitamin DVitaminsAtopic dermatitisChronic urticariaContact dermatitisPsoriasisVitamin DVitamin D deficiency

Identifiers

PMID41340803
PMCPMC12671712

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.